TY - STD TI - Andoniadou CL, Gaston-Massuet C, Reddy R, Schneider RP, Blasco MA, Le Tissier P, Jacques TS, Pevny LH, Dattani MT, Martinez-Barbera JP. Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma. Acta Neuropathol. 2012;124:259–71. ID - ref1 ER - TY - STD TI - Andoniadou CL, Matsushima D, Mousavy Gharavy SN, Signore M, Mackintosh AI, Schaeffer M, Gaston-Massuet C, Mollard P, Jacques TS, Le Tissier P, Dattani MT, Pevny LH, Martinez-Barbera JP. Sox2(+) stem/progenitor cells in the adult mouse pituitary support organ homeostasis and have tumor-inducing potential. Cell Stem Cell. 2013;13:433–45. ID - ref2 ER - TY - BOOK AU - Aylwin, S. J. AU - Bodi, I. AU - Beaney, R. PY - 2015 DA - 2015// TI - Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor ID - Aylwin2015 ER - TY - STD TI - Brastianos PK, Shankar GM, Gill CM, Taylor-Weiner A, Nayyar N, Panka DJ, Sullivan RJ, Frederick DT, Abedalthagafi M, Jones PS, Dunn IF, Nahed BV, Romero JM, Louis DN, Getz G, Cahill DP, Santagata S, Curry WT, Jr., Barker FG. 2nd Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy. J Natl Cancer Inst. 2015;108(2). pii: djv310. doi:10.1093/jnci/djv310. ID - ref4 ER - TY - STD TI - Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, Thorner AR, Lawrence MS, Rodriguez FJ, Bernardo LA, Schubert L, Sunkavalli A, Shillingford N, Calicchio ML, Lidov HG, Taha H, Martinez-Lage M, Santi M, Storm PB, Lee JY, Palmer JN, Adappa ND, Scott RM, Dunn IF, Laws ER, Jr., Stewart C, Ligon KL, Hoang MP, Van Hummelen P, Hahn WC, Louis DN, Resnick AC, Kieran MW, Getz G, Santagata S. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. 2014;46:161–5. ID - ref5 ER - TY - JOUR AU - Budowle, B. AU - Chakraborty, R. AU - Giusti, A. M. AU - Eisenberg, A. J. AU - Allen, R. C. PY - 1991 DA - 1991// TI - Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE JO - Am J Hum Genet VL - 48 ID - Budowle1991 ER - TY - JOUR AU - Bunin, G. R. AU - Surawicz, T. S. AU - Witman, P. A. AU - Preston-Martin, S. AU - Davis, F. AU - Bruner, J. M. PY - 1998 DA - 1998// TI - The descriptive epidemiology of craniopharyngioma JO - J Neurosurg VL - 89 UR - https://doi.org/10.3171/jns.1998.89.4.0547 DO - 10.3171/jns.1998.89.4.0547 ID - Bunin1998 ER - TY - STD TI - Burghaus S, Holsken A, Buchfelder M, Fahlbusch R, Riederer BM, Hans V, Blumcke I, Buslei R. A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas. Virchows Arch. 2010;456:287–300. ID - ref8 ER - TY - STD TI - Buslei R, Holsken A, Hofmann B, Kreutzer J, Siebzehnrubl F, Hans V, Oppel F, Buchfelder M, Fahlbusch R, Blumcke I. Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas. Acta Neuropathol. 2007;113:585–90. ID - ref9 ER - TY - STD TI - Buslei R, Nolde M, Hofmann B, Meissner S, Eyupoglu IY, Siebzehnrubl F, Hahnen E, Kreutzer J, Fahlbusch R. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol. 2005;109:589–97. ID - ref10 ER - TY - STD TI - Capper D, Preusser M, Habel A, Sahm F, Ackermann U, Schindler G, Pusch S, Mechtersheimer G, Zentgraf H, von Deimling A. Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody. Acta Neuropathol. 2011;122:11–9. ID - ref11 ER - TY - STD TI - Crotty TB, Scheithauer BW, Young Jr WF, Davis DH, Shaw EG, Miller GM, Burger PC. Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg. 1995;83:206–14. ID - ref12 ER - TY - STD TI - Dias-Santagata D, Lam Q, Vernovsky K, Vena N, Lennerz JK, Borger DR, Batchelor TT, Ligon KL, Iafrate AJ, Ligon AH, Louis DN, Santagata S. BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications. PLoS One. 2011;6, e17948. ID - ref13 ER - TY - JOUR AU - Dietrich, S. AU - Glimm, H. AU - Andrulis, M. AU - Kalle, C. AU - Ho, A. D. AU - Zenz, T. PY - 2012 DA - 2012// TI - BRAF inhibition in refractory hairy-cell leukemia JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMc1202124 DO - 10.1056/NEJMc1202124 ID - Dietrich2012 ER - TY - JOUR AU - Dolecek, T. A. AU - Propp, J. M. AU - Stroup, N. E. AU - Kruchko, C. PY - 2012 DA - 2012// TI - CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009 JO - Neuro Oncol VL - 14 UR - https://doi.org/10.1093/neuonc/nos218 DO - 10.1093/neuonc/nos218 ID - Dolecek2012 ER - TY - STD TI - Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, O'Dwyer PJ, Lee RJ, Grippo JF, Nolop K, Chapman PB. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med. 2010;363:809–19. ID - ref16 ER - TY - STD TI - Garcia-Lavandeira M, Saez C, Diaz-Rodriguez E, Perez-Romero S, Senra A, Dieguez C, Japon MA, Alvarez CV. Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET/GFRA3 receptors. J Clin Endocrinol Metab. 2012;97:E80–7. ID - ref17 ER - TY - STD TI - Gaston-Massuet C, Andoniadou CL, Signore M, Jayakody SA, Charolidi N, Kyeyune R, Vernay B, Jacques TS, Taketo MM, Le Tissier P, Dattani MT, Martinez-Barbera JP. Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans. Proc Natl Acad Sci U S A. 2011;108:11428–7. ID - ref18 ER - TY - STD TI - Gjerris F, Agerlin N, Borgesen SE, Buhl L, Haase J, Klinken L, Mortensen AC, Olsen JH, Ovesen N, Reske-Nielsen E, Schmidt K. Epidemiology and prognosis in children treated for intracranial tumours in Denmark 1960–1984. Childs Nerv Syst. 1998;14:302–11. ID - ref19 ER - TY - STD TI - Gump JM, Donson AM, Birks DK, Amani VM, Rao KK, Griesinger AM, Kleinschmidt-DeMasters BK, Johnston JM, Anderson RC, Rosenfeld A, Handler M, Gore L, Foreman N, Hankinson TC. Identification of targets for rational pharmacological therapy in childhood craniopharyngioma. Acta Neuropathol Commun. 2015;3:30. ID - ref20 ER - TY - STD TI - Hofmann BM, Kreutzer J, Saeger W, Buchfelder M, Blumcke I, Fahlbusch R, Buslei R. Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and rathke cleft cysts: a clinico-pathologic approach. Am J Surg Pathol. 2006;30:1595–603. ID - ref21 ER - TY - JOUR AU - Holsken, A. AU - Buchfelder, M. AU - Fahlbusch, R. AU - Blumcke, I. AU - Buslei, R. PY - 2010 DA - 2010// TI - Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling JO - Acta Neuropathol VL - 119 UR - https://doi.org/10.1007/s00401-010-0642-9 DO - 10.1007/s00401-010-0642-9 ID - Holsken2010 ER - TY - JOUR AU - Holsken, A. AU - Gebhardt, M. AU - Buchfelder, M. AU - Fahlbusch, R. AU - Blumcke, I. AU - Buslei, R. PY - 2011 DA - 2011// TI - EGFR signaling regulates tumor cell migration in craniopharyngiomas JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-2811 DO - 10.1158/1078-0432.CCR-10-2811 ID - Holsken2011 ER - TY - STD TI - Holsken A, Kreutzer J, Hofmann BM, Hans V, Oppel F, Buchfelder M, Fahlbusch R, Blumcke I, Buslei R. Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas. Brain Pathol. 2009;19:357–64. ID - ref24 ER - TY - STD TI - Holsken A, Stache C, Schlaffer SM, Flitsch J, Fahlbusch R, Buchfelder M, Buslei R. Adamantinomatous craniopharyngiomas express tumor stem cell markers in cells with activated Wnt signaling: further evidence for the existence of a tumor stem cell niche? Pituitary. 2014;17:546–56. ID - ref25 ER - TY - JOUR AU - Karavitaki, N. AU - Cudlip, S. AU - Adams, C. B. AU - Wass, J. A. PY - 2006 DA - 2006// TI - Craniopharyngiomas JO - Endocr Rev VL - 27 UR - https://doi.org/10.1210/er.2006-0002 DO - 10.1210/er.2006-0002 ID - Karavitaki2006 ER - TY - JOUR AU - Karavitaki, N. AU - Wass, J. A. PY - 2008 DA - 2008// TI - Craniopharyngiomas JO - Endocrinol Metab Clin North Am VL - 37 UR - https://doi.org/10.1016/j.ecl.2007.10.012 DO - 10.1016/j.ecl.2007.10.012 ID - Karavitaki2008 ER - TY - STD TI - Kato K, Nakatani Y, Kanno H, Inayama Y, Ijiri R, Nagahara N, Miyake T, Tanaka M, Ito Y, Aida N, Tachibana K, Sekido K, Tanaka Y. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol. 2004;203:814–21. ID - ref28 ER - TY - JOUR AU - Kim, J. H. AU - Paulus, W. AU - Heim, S. PY - 2015 DA - 2015// TI - BRAF V600E mutation is a useful marker for differentiating Rathke’s cleft cyst with squamous metaplasia from papillary craniopharyngioma JO - J Neurooncol VL - 123 UR - https://doi.org/10.1007/s11060-015-1757-6 DO - 10.1007/s11060-015-1757-6 ID - Kim2015 ER - TY - JOUR AU - Larkin, S. J. AU - Preda, V. AU - Karavitaki, N. AU - Grossman, A. AU - Ansorge, O. PY - 2014 DA - 2014// TI - BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma JO - Acta Neuropathol VL - 127 UR - https://doi.org/10.1007/s00401-014-1270-6 DO - 10.1007/s00401-014-1270-6 ID - Larkin2014 ER - TY - BOOK AU - Louis, D. N. AU - Ohgaki, H. AU - Wiestler, O. D. AU - Cavenee, W. K. PY - 2007 DA - 2007// TI - WHO Classification of Tumours of the Central Nervous System ID - Louis2007 ER - TY - STD TI - Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109. ID - ref32 ER - TY - STD TI - MacConaill LE, Campbell CD, Kehoe SM, Bass AJ, Hatton C, Niu L, Davis M, Yao K, Hanna M, Mondal C, Luongo L, Emery CM, Baker AC, Philips J, Goff DJ, Fiorentino M, Rubin MA, Polyak K, Chan J, Wang Y, Fletcher JA, Santagata S, Corso G, Roviello F, Shivdasani R, Kieran MW, Ligon KL, Stiles CD, Hahn WC, Meyerson ML, Garraway LA. Profiling critical cancer gene mutations in clinical tumor samples. PLoS One. 2009;4, e7887. ID - ref33 ER - TY - JOUR AU - Martinez-Barbera, J. P. AU - Buslei, R. PY - 2015 DA - 2015// TI - Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models JO - J Pediatr Endocrinol Metab VL - 28 UR - https://doi.org/10.1515/jpem-2014-0442 DO - 10.1515/jpem-2014-0442 ID - Martinez-Barbera2015 ER - TY - JOUR AU - Monti, S. AU - Tamayo, P. AU - Mesirov, J. AU - Golub, T. PY - 2003 DA - 2003// TI - Consensus Clustering: A Resampling-Based Method for Class Discovery and Visualization of Gene Expression Microarray Data JO - Machine Learning VL - 52 UR - https://doi.org/10.1023/A:1023949509487 DO - 10.1023/A:1023949509487 ID - Monti2003 ER - TY - JOUR AU - Muller, H. L. PY - 2010 DA - 2010// TI - Childhood craniopharyngioma: current controversies on management in diagnostics, treatment and follow-up JO - Expert Rev Neurother VL - 10 UR - https://doi.org/10.1586/ern.10.15 DO - 10.1586/ern.10.15 ID - Muller2010 ER - TY - JOUR AU - Muller, H. L. PY - 2014 DA - 2014// TI - Craniopharyngioma JO - Handb Clin Neurol VL - 124 UR - https://doi.org/10.1016/B978-0-444-59602-4.00016-2 DO - 10.1016/B978-0-444-59602-4.00016-2 ID - Muller2014 ER - TY - STD TI - Muller HL, Gebhardt U, Teske C, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Pohl F, Sorensen N, Calaminus G. Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur J Endocrinol. 2011;165:17–24. ID - ref38 ER - TY - STD TI - Nielsen EH, Feldt-Rasmussen U, Poulsgaard L, Kristensen LO, Astrup J, Jorgensen JO, Bjerre P, Andersen M, Andersen C, Jorgensen J, Lindholm J, Laurberg P. Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults. J Neurooncol. 2011;104:755–63. ID - ref39 ER - TY - STD TI - Okada T, Fujitsu K, Ichikawa T, Mukaihara S, Miyahara K, Kaku S, Uryuu Y, Niino H, Yagishita S, Shiina T. Coexistence of adamantinomatous and squamous‐papillary type craniopharyngioma: Case report and discussion of etiology and pathology. Neuropathology. 2012;32:171–3. ID - ref40 ER - TY - JOUR AU - Prieto, R. AU - Pascual, J. M. AU - Subhi-Issa, I. AU - Jorquera, M. AU - Yus, M. AU - Martinez, R. PY - 2013 DA - 2013// TI - Predictive factors for craniopharyngioma recurrence: a systematic review and illustrative case report of a rapid recurrence JO - World Neurosurg VL - 79 UR - https://doi.org/10.1016/j.wneu.2012.07.033 DO - 10.1016/j.wneu.2012.07.033 ID - Prieto2013 ER - TY - JOUR AU - Rosemberg, S. AU - Fujiwara, D. PY - 2005 DA - 2005// TI - Epidemiology of pediatric tumors of the nervous system according to the WHO 2000 classification: a report of 1,195 cases from a single institution JO - Childs Nerv Syst VL - 21 UR - https://doi.org/10.1007/s00381-005-1181-x DO - 10.1007/s00381-005-1181-x ID - Rosemberg2005 ER - TY - STD TI - Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, Schmieder K, Wesseling P, Mawrin C, Hasselblatt M, Louis DN, Korshunov A, Pfister S, Hartmann C, Paulus W, Reifenberger G, von Deimling A. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol. 2011;121:397–405. ID - ref43 ER - TY - STD TI - Schweizer L, Capper D, Holsken A, Fahlbusch R, Flitsch J, Buchfelder M, Herold-Mende C, von Deimling A, Buslei R. BRAF V600E analysis for the differentiation of papillary Craniopharyngiomas and Rathke's Cleft Cysts. 2014. Neuropathol Appl Neurobiol. ID - ref44 ER - TY - STD TI - Sekine S, Shibata T, Kokubu A, Morishita Y, Noguchi M, Nakanishi Y, Sakamoto M, Hirohashi S. Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol. 2002;161:1997–2001. ID - ref45 ER - TY - STD TI - Sekine S, Takata T, Shibata T, Mori M, Morishita Y, Noguchi M, Uchida T, Kanai Y, Hirohashi S. Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma: evidence for its odontogenic epithelial differentiation. Histopathology. 2004;45:573–9. ID - ref46 ER - TY - STD TI - Stache C, Holsken A, Fahlbusch R, Flitsch J, Schlaffer SM, Buchfelder M, Buslei R. Tight junction protein claudin-1 is differentially expressed in craniopharyngioma subtypes and indicates invasive tumor growth. Neuro Oncol. 2014;16:256–64. ID - ref47 ER - TY - STD TI - Stache C, Holsken A, Schlaffer SM, Hess A, Metzler M, Frey B, Fahlbusch R, Flitsch J, Buchfelder M, Buslei R. Insights into the infiltrative behavior of adamantinomatous craniopharyngioma in a new xenotransplant mouse model. Brain Pathol. 2015;25:1–10. ID - ref48 ER - TY - STD TI - Weiner HL, Wisoff JH, Rosenberg ME, Kupersmith MJ, Cohen H, Zagzag D, Shiminski-Maher T, Flamm ES, Epstein FJ, Miller DC. Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery. 1994;35:1001–10. discussion 1010–1001. ID - ref49 ER -